Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks

Counterfeit drugs are inherently dangerous and a growing problem; counterfeiters are becoming increasingly sophisticated. Growth of the counterfeit medication market is attributable in part to phosphodiesterase type 5 inhibitor (PDE5i) medications for erectile dysfunction (ED). Millions of counterfe...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, G, Arver, S, Banks, I, Stecher, V J
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2010
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069491/
https://www.ncbi.nlm.nih.gov/pubmed/20088883
http://dx.doi.org/10.1111/j.1742-1241.2009.02328.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069491/
https://www.ncbi.nlm.nih.gov/pubmed/20088883
http://dx.doi.org/10.1111/j.1742-1241.2009.02328.x

Ejemplares similares